Ketamine Reduces Suicidality In Depressed Patients, Mount Sinai School of Medicine Study

EurekAlert! -- Philadelphia, PA, 10 September 2009 - Drug treatment options for depression can take weeks for the beneficial effects to emerge, which is clearly inadequate for those at immediate risk of suicide. However, intravenous (IV) ketamine, a drug previously used as an anesthetic, has shown rapid antidepressant effects in early trials.

MORE ON THIS TOPIC